Moreover, the expression levels of ERα and ERβ, based on immunohistochemical staining, have been correlated with prognosis in female patients with advanced ESCC, and ERα expression or ERβ non-expression are associated with poor prognosis51. This evidence concerns the gene ESR2 and esophageal squamous cell carcinoma.